BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23522634)

  • 1. Medical makeup: the correction of hyperpigmentation disorders.
    Nonni J
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S170-6. PubMed ID: 23522634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical makeup: the correction of hyperpigmentation disorders].
    Nonni J
    Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S119-24. PubMed ID: 23260520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cosmetic camouflaging techniques.
    Draelos ZK
    Cutis; 1993 Dec; 52(6):362-4. PubMed ID: 8293678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperpigmentation and melasma.
    Rigopoulos D; Gregoriou S; Katsambas A
    J Cosmet Dermatol; 2007 Sep; 6(3):195-202. PubMed ID: 17760699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colored facial cosmetics.
    Draelos ZD
    Dermatol Clin; 2000 Oct; 18(4):621-31. PubMed ID: 11059370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural options for the management of hyperpigmentation.
    Leyden JJ; Shergill B; Micali G; Downie J; Wallo W
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1140-5. PubMed ID: 21623927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of two commercial hyperpigmentation kits in the treatment of facial hyperpigmentation and photo-aging.
    Fabi S; Massaki N; Goldman MP
    J Drugs Dermatol; 2012 Aug; 11(8):964-8. PubMed ID: 22859242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camouflage therapy.
    Rayner VL
    Dermatol Clin; 1995 Apr; 13(2):467-72. PubMed ID: 7600717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermocosmetic management of hyperpigmentations.
    Guerrero D
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S166-9. PubMed ID: 23522633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cosmetic efficacy evaluation of an anti-acne cream using the 3D image analysis system.
    Choi KM; Kim SJ; Baek JH; Kang SJ; Boo YC; Koh JS
    Skin Res Technol; 2012 May; 18(2):192-8. PubMed ID: 22471840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kojic acid applications in cosmetic and pharmaceutical preparations.
    Saeedi M; Eslamifar M; Khezri K
    Biomed Pharmacother; 2019 Feb; 110():582-593. PubMed ID: 30537675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
    Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
    Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dermocosmetic management of hyperpigmentations].
    Guerrero D
    Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S115-8. PubMed ID: 23260519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of action and clinical benefits of soy for the treatment of hyperpigmentation.
    Leyden J; Wallo W
    Int J Dermatol; 2011 Apr; 50(4):470-7. PubMed ID: 21332714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facial skin care products and cosmetics.
    Draelos ZD
    Clin Dermatol; 2014; 32(6):809-12. PubMed ID: 25441474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cosmetic problems in skin of color.
    Taylor SC
    Skin Pharmacol Appl Skin Physiol; 1999; 12(3):139-43. PubMed ID: 10393522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrective cosmetics are effective for women with facial pigmentary disorders.
    Balkrishnan R; McMichael AJ; Hu JY; Camacho FT; Kaur M; Bouloc A; Rapp SR; Feldman SR
    Cutis; 2005 Mar; 75(3):181-7. PubMed ID: 15839363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of castor oil cream in treating infraorbital hyperpigmentation: An exploratory single-arm clinical trial.
    Parvizi MM; Saki N; Samimi S; Radanfer R; Shahrizi MM; Zarshenas MM
    J Cosmet Dermatol; 2024 Mar; 23(3):911-917. PubMed ID: 37927123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to treatment of medical and cosmetic facial concerns in skin of color patients.
    Callender VD; Barbosa V; Burgess CM; Heath C; McMichael AJ; Ogunleye T; Taylor SC
    Cutis; 2017 Dec; 100(6):375-380. PubMed ID: 29360898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine.
    Bissett DL; Robinson LR; Raleigh PS; Miyamoto K; Hakozaki T; Li J; Kelm GR
    J Cosmet Dermatol; 2007 Mar; 6(1):20-6. PubMed ID: 17348991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.